Warner Group’s AbbVie ABBV Stock Holding History

Warner Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$864K	Buy	3,432 +1,749	+104%	+$376K	0.21%	57
2026 Q1	$366K	Buy	1,683 +615	+58%	+$136K	0.24%	53
2025 Q4	$244K	Buy	1,068 +116	+12%	+$26.4K	0.15%	65
2025 Q3	$220K	Buy	+952	New	+$194K	0.15%	58

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Warner Group's ABBV Position: Q2 2026 in Review

Warner Group increased its AbbVie (ABBV) stake by 104% in Q2 2026, buying an estimated $376K and bringing the position to 3,432 shares worth $864K. The position accounts for 0.21% of the portfolio, ranked #57.

Warner Group first reported a position in ABBV in Q3 2025 and has held it in 4 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Warner Group held 3,432 shares of AbbVie worth $864K as of Q2 2026.
Warner Group bought 1,749 AbbVie shares in Q2 2026, an estimated $376K.
AbbVie made up 0.21% of Warner Group's portfolio in Q2 2026, its #57 holding.
Warner Group first reported a position in AbbVie in Q3 2025 and has held it in 4 quarters since.
4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Warner Group's 13F filing for Q2 2026, filed 27 Jul 2026.